NASDAQ:MOTS Motus GI (MOTS) Stock Price, News & Analysis $0.0001 +0.00 (+∞) As of 06/12/2026 12:13 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsSEC FilingsTrendsBuy This Stock About Motus GI Stock (NASDAQ:MOTS) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Motus GI alerts:Sign Up Key Stats Today's Range$0.0001▼$0.000150-Day Range N/A52-Week Range$0.00▼$0.10Volume50,010 shsAverage Volume7,640 shsMarket Capitalization$576.90P/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Motus GI Holdings, Inc. is a clinical-stage medical technology company developing advanced endoscopic solutions for the minimally invasive diagnosis and treatment of gastrointestinal disorders. The company’s platform is designed to improve procedural control, stability and precision during complex therapeutic interventions in the GI tract, such as tissue resection, hemostasis and suturing. By integrating electromechanical instruments into a single-use device, Motus GI aims to enhance clinical efficiency and patient outcomes compared with conventional flexible endoscopes. The company’s lead product candidate is an electromechanical endoscopy system built around a multifunctional, disposable module that delivers stable instrument control and intuitive maneuverability. The platform incorporates proprietary motorized elements and disposable accessory channels, enabling physicians to perform a broad spectrum of advanced therapeutic procedures through natural orifice access. Motus GI has secured intellectual property covering instrument actuation, device assembly and system control software, and is conducting pre-commercial and clinical validation studies in the United States. Headquartered in California, Motus GI serves hospitals, ambulatory surgery centers and endoscopy clinics across North America. Its management team brings extensive experience in medical device development, regulatory affairs and commercialization for minimally invasive surgical technologies. The company continues to advance its clinical and regulatory programs, positioning its platform for future market entry in the United States and select international markets.AI Generated. May Contain Errors. Read More Receive MOTS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Motus GI and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. MOTS Stock News HeadlinesMOTS Motus GI Holdings, Inc. - Seeking AlphaJuly 2, 2025 | seekingalpha.comMotus GI Hldgs (OTC:MOTS) Stock, Insider Trading ActivityDecember 13, 2024 | benzinga.comHow to play the Biggest IPO in stock market history!SpaceX is eyeing a near-$2 trillion IPO valuation, and retail investors are already lining up - but early insiders and institutional holders have been sitting on positions for years and will exit the moment shares hit the market. Lance Ippolito has identified five stocks directly positioned to benefit from the SpaceX launch and the space investing wave it triggers, without the brutal IPO volatility. These picks carry none of the hype risk and all of the tailwind.June 14 at 1:00 AM | InvestPub (Ad)Motus GI Hldgs (OTC:MOTS) Stock, Short Interest ReportOctober 6, 2024 | benzinga.comMotus GI Hldgs (OTC:MOTS) Stock Quotes, Forecast and News SummaryOctober 6, 2024 | benzinga.comMotus GI annonce la démission de son conseil d'administration et l'arrêt de ses activitésJuly 31, 2024 | fr.investing.comMOTS Stock Earnings: Motus GI Hldgs Beats EPS, Misses Revenue for Q1 2024May 14, 2024 | msn.comMotus GI Reports First Quarter 2024 Financial Results and Provides Corporate UpdateMay 14, 2024 | finance.yahoo.comSee More Headlines MOTS Stock Analysis - Frequently Asked Questions How have MOTS shares performed this year? Motus GI's stock was trading at $0.0001 at the start of the year. Since then, MOTS stock has increased by 0.0% and is now trading at $0.0001. How were Motus GI's earnings last quarter? Motus GI Holdings, Inc. (NASDAQ:MOTS) issued its quarterly earnings results on Friday, November, 12th. The company reported ($30.00) earnings per share for the quarter, hitting the consensus estimate of ($30.00). The company earned $0.14 million during the quarter, compared to the consensus estimate of $0.12 million. When did Motus GI's stock split? Motus GI shares reverse split on the morning of Thursday, November 2nd 2023.The 1-15 reverse split was announced on Wednesday, November 1st 2023. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, November 1st 2023. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split. When did Motus GI IPO? Motus GI (MOTS) raised $21 million in an initial public offering on Wednesday, February 14th 2018. The company issued 3,500,000 shares at a price of $5.00-$7.00 per share. Piper Jaffray acted as the underwriter for the IPO and Oppenheimer & Co. was co-manager. How do I buy shares of Motus GI? Shares of MOTS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Motus GI own? Based on aggregate information from My MarketBeat watchlists, some other companies that Motus GI investors own include Inovio Pharmaceuticals (INO), Matinas Biopharma (MTNB), NIO (NIO), Tesla (TSLA), Bionano Genomics (BNGO), Pfizer (PFE). Company Calendar Last Earnings11/12/2021Today6/14/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryMedical Equipment Current SymbolNASDAQ:MOTS CIK1686850 Webwww.motusgi.com Phone(954) 541-8000Fax954-541-8265Employees30Year Founded2010Profitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$319 thousand Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book Value$1.74 per share Price / Book0.00Miscellaneous Outstanding Shares5,769,000Free Float5,749,000Market Cap$576.90 OptionableNot Optionable Beta0.82 Social Links 7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleLooking for the next FAANG stock before everyone has heard about it? Click the link to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.Get This Free Report This page (NASDAQ:MOTS) was last updated on 6/14/2026 by MarketBeat.com Staff. From Our PartnersDOJ Admits It In Court—Your Cash Can Be Seized Without WarningThe Department of Justice recently argued in court that cash may not be legally your property - raising concer...Priority Gold | SponsoredIs SpaceX really worth 1.78 Trillion?With SpaceX approaching a near-$2 trillion valuation, most investors are focused on the IPO itself - but analy...InvestPub | SponsoredThis Could Be the Biggest Monetary Shift in 50 YearsTucked inside U.S. Code Title 31, Section 5117 is a provision allowing the Treasury to reprice America's gold ...Americas Gold Company | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredThis is the worst news for stocks in 50 yearsGoldman Sachs and Morgan Stanley are issuing a rare warning: what's ahead for U.S. stocks could be the worst e...TradeSmith | SponsoredDo NOT Buy SpaceX – Do This InsteadSpaceX is set to go public as soon as June 11, with OpenAI and Anthropic likely to follow. Whitney Tilson - Ha...Stansberry Research | SponsoredFrom the man who predicted 2008 crash…Porter Stansberry, founder of one of the largest financial research firms in the world, says he's breaking the...Porter & Company | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Motus GI Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Motus GI With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
